{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:56:59Z","timestamp":1792792619457,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011721","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000}}],"reference-count":122,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011721.pub2","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T11:00:05Z","timestamp":1453546805000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta<sub>2<\/sub>-agonists and inhaled corticosteroids (LABA\/ICS) versus LABA\/ICS for adults with asthma"],"prefix":"10.1002","volume":"2016","author":[{"given":"Kayleigh M","family":"Kew","sequence":"first","affiliation":[{"name":"St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dahri","sequence":"additional","affiliation":[{"name":"Vancouver General Hospital; Vancouver BC Canada"},{"name":"University of British Columbia; Faculty of Pharmaceutical Sciences; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD011721.pub2-BIB0001|cit1","first-page":"57","article-title":"Tiotropium Respimat add-on therapy to inhaled corticosteroids (ICS) + long-acting beta2-agonists (LABAs) in patients with symptomatic severe asthma: efficacy by level of airway obstruction","volume":"23","author":"Beck","year":"2014","journal-title":"Allergo Journal"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Bernstein JA Kerstjens HAM Moroni-Zentgraf P Engel M Schmidt H Halpin DMG Once-daily tiotropium is well tolerated as add-on to standard treatment for patients with symptomatic asthma despite receiving inhaled corticosteroids and long-acting beta 2 -agonists CHEST Annual Conference; 2013 October 26-31; Chicago 2013","DOI":"10.1378\/chest.1701649"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0003|cit3","unstructured":"Casale TB Dahl R Virchow JC Engel M Moroni-Zentgraf P Luehmann R Tiotropium respimat add-on therapy reduces exacerbation risk in patients with symptomatic moderate to severe asthma, independent of t helper 2 status American Thoracic Society International Conference; 2015 May 15-20; Denver 2015 A4193"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Corren J Frew A Engel M Schmidt H Moroni-Zentgraf P Kerstjens HAM Tiotropium as add-on therapy to ICS+LABA in patients with symptomatic severe asthma: spirometric assessment over 24 hours [Abstract] American College of Chest Physicians Annual Meeting; 2013 Oct 26-31; Chicago 2013 91A","DOI":"10.1378\/chest.1702134"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0005|cit5","first-page":"S157","article-title":"Once-daily tiotropium Respimat decreases the risk of exacerbations, independent of baseline characteristics, in patients with symptomatic severe asthma without evidence of chronic obstructive pulmonary disease","volume":"29","author":"Corren","year":"2014","journal-title":"Journal of General Internal Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"A177","DOI":"10.1136\/thoraxjnl-2014-206260.357","article-title":"Once-daily tiotropium Respimat as add-on to at least medium-to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status","volume":"69","author":"Dahl","year":"2014","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"AB5","DOI":"10.1016\/j.jaci.2013.12.041","article-title":"Once-daily tiotropium respimat improves lung function in patients with severe symptomatic asthma independent of leukotriene modifier use","volume":"133","author":"Dahl","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"s98","key":"10.1002\/14651858.CD011721.pub2-BIB0008|cit8","first-page":"40","article-title":"Once-daily tiotropium improves lung function and reduces risk of asthma exacerbation\/worsening in patients with symptomatic asthma, regardless of allergic status","volume":"68","author":"Dahl","year":"2013","journal-title":"Allergy"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0009|cit9","unstructured":"Doherty DE Castro M Moroni-Zentgraf P Engel M Luehmann R Buhl R Tiotropium respimat add-on therapy improves lung function, as measured by peak expiratory flow, in adult patients across severities of symptomatic asthma American Thoracic Society International Conference; 2015 May 15-20; Denver 2015 A4258"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"88A","DOI":"10.1378\/chest.1702143","article-title":"Improvements in lung function with tiotropium as add-on controller therapy to ICS+LABA for patients with symptomatic severe asthma","volume":"144","author":"Doherty","year":"2013","journal-title":"Chest"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0011|cit11","unstructured":"FitzGerald JM Engel M Moroni-Zentgraf P Luehmann R Bleecker ER Once-daily tiotropium respimat add-on therapy improves symptom control across severities of symptomatic asthma, independent of allergic status American Thoracic Society Internation Conference; 2015 May 15-20; Denver 2015 A4263"},{"issue":"Suppl S2","key":"10.1002\/14651858.CD011721.pub2-BIB0012|cit12","first-page":"137","article-title":"Efficacy of once-daily tiotropium respimat 5 \u03bcg from five phase III trials in adults with symptomatic asthma","volume":"20","author":"Frith","year":"2015","journal-title":"Respirology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011721.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"A152","DOI":"10.1136\/thoraxjnl-2013-204457.320","article-title":"Tiotropium is effective in patients with severe asthma without evidence of chronic obstructive pulmonary disease","volume":"68","author":"Halpin","year":"2013","journal-title":"Thorax"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011721.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"A149","DOI":"10.1136\/thoraxjnl-2013-204457.314","article-title":"Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics including markers of allergic status","volume":"68","author":"Halpin","year":"2013","journal-title":"Thorax"},{"issue":"S2","key":"10.1002\/14651858.CD011721.pub2-BIB0015|cit15","first-page":"88","article-title":"Once-daily tiotropium as add-on to ICS + LABA for patients with severe symptomatic asthma: baseline characteristics in Japanese patients","volume":"18","author":"Hashimoto","year":"2013","journal-title":"Respirology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011721.pub2-BIB0016|cit16","first-page":"A149","article-title":"Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics","volume":"18","author":"Hozawa","year":"2013","journal-title":"Respirology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0017|cit17","first-page":"A483","article-title":"Tiotropium reduces asthma exacerbations in patients with uncontrolled asthma and persistent airflow obstruction despite treatment in accordance with guidelines","volume":"17","author":"Kerstjens","year":"2012","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0018|cit18","first-page":"A1312","article-title":"Tiotropium Respimat\u00ae add-on therapy to inhaled corticosteroids (ICS) + long-acting \u03922-agonists (LABAS) in patients with symptomatic severe asthma: efficacy by level of airway obstruction [Abstract]","volume":"189","author":"Kerstjens","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"13","key":"10.1002\/14651858.CD011721.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"s98","key":"10.1002\/14651858.CD011721.pub2-BIB0020|cit20","first-page":"41","article-title":"Tiotropium added to inhaled corticosteroids and long-acting beta(2)-agonists reduces episodes of asthma worsening, irrespective of selected patient baseline characteristics","volume":"68","author":"Kerstjens","year":"2013","journal-title":"Allergy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0021|cit21","first-page":"6 [221]","article-title":"Tiotropium provides sustained bronchodilation in patients with uncontrolled asthma and persistent airflow obstruction despite treatment in accordance with guidelines [Abstract]","volume":"17","author":"Kerstjens","year":"2012","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0022|cit22","unstructured":"NCT00772538 A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat \u00ae inhaler (5 \u03bcg\/day) over 48 weeks as add-on controller therapy on top of usual care in patients with severe persistent asthma https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2008-001413-14\/results"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0023|cit23","unstructured":"NCT00772538 Evaluation of tiotropium 5 \u00b5g\/day delivered via the Respimat\u00ae inhaler over 48 weeks in patients with severe persistent asthma on top of usual care (study I) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00772538"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"A49","DOI":"10.1136\/thoraxjnl-2014-206260.97","article-title":"Once-daily tiotropium respimat add-on to ICS + LABA improves symptom control and reduces exacerbations in patients with symptomatic asthma","volume":"69","author":"Price","year":"2014","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1378\/chest.1994283","article-title":"Once-daily tiotropium respimat add-on to ICS+LABA reduces risk of severe exacerbation and asthma worsening in patients with asthma, independent of degree of airflow obstruction","volume":"146","author":"Tashkin","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"90A","DOI":"10.1378\/chest.1701739","article-title":"Once-daily tiotropium reduces risk of exacerbations and asthma worsening in patients with symptomatic asthma despite treatment with inhaled corticosteroids and long-acting beta2-agonists","volume":"144","author":"Tashkin","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"AB1","DOI":"10.1016\/j.jaci.2012.12.680","article-title":"Efficacy of tiotropium in patients with asthma in relation to allergic status [Abstract]","volume":"131","author":"Vandewalker","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0028|cit28","first-page":"A105","article-title":"Once-daily tiotropium Respimat add-on to maintenance therapy improves lung function in patients with moderate or severe symptomatic asthma, independent of T helper 2 inflammatory status","volume":"113","author":"Vandewalker","year":"2014","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0029|cit29","unstructured":"2008-001414-25 A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat \u00ae inhaler (5 \u03bcg\/day) over 48 weeks as add-on controller therapy on top of usual care in patients with severe persistent asthma https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2008-001414-25\/results"},{"issue":"6","key":"10.1002\/14651858.CD011721.pub2-BIB0030|cit30","first-page":"57","article-title":"Tiotropium Respimat add-on therapy to inhaled corticosteroids (ICS) + long-acting beta2-agonists (LABAs) in patients with symptomatic severe asthma: efficacy by level of airway obstruction","volume":"23","author":"Beck","year":"2014","journal-title":"Allergo Journal"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0031|cit31","doi-asserted-by":"crossref","unstructured":"Bernstein JA Kerstjens HAM Moroni-Zentgraf P Engel M Schmidt H Halpin DMG Once-daily tiotropium is well tolerated as add-on to standard treatment for patients with symptomatic asthma despite receiving inhaled corticosteroids and long-acting beta 2 -agonists CHEST Annual Conference; 2013 October 26-31 2013","DOI":"10.1378\/chest.1701649"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0032|cit32","unstructured":"Casale TB Dahl R Virchow JC Engel M Moroni-Zentgraf P Luehmann R Tiotropium respimat add-on therapy reduces exacerbation risk in patients with symptomatic moderate to severe asthma, independent of t helper 2 status American Thoracic Society International Conference; 2015 May 15-20; Denver 2015 A4193"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Corren J Frew A Engel M Schmidt H Moroni-Zentgraf P Kerstjens HAM Tiotropium as add-on therapy to ICS+LABA in patients with symptomatic severe asthma: spirometric assessment over 24 hours [Abstract] American College of Chest Physicians Annual Meeting; 2013 Oct 26-31; Chicago, Illinois 2013 91A","DOI":"10.1378\/chest.1702134"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0034|cit34","first-page":"S157","article-title":"Once-daily tiotropium respimat decreases the risk of exacerbations, independent of baseline characteristics, in patients with symptomatic severe asthma without evidence of chronic obstructive pulmonary disease","volume":"29","author":"Corren","year":"2014","journal-title":"Journal of General Internal Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"A177","DOI":"10.1136\/thoraxjnl-2014-206260.357","article-title":"Once-daily tiotropium Respimat as add-on to at least medium-to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status","volume":"69","author":"Dahl","year":"2014","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"AB5","DOI":"10.1016\/j.jaci.2013.12.041","article-title":"Once-daily tiotropium respimat improves lung function in patients with severe symptomatic asthma independent of leukotriene modifier use","volume":"133","author":"Dahl","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"s98","key":"10.1002\/14651858.CD011721.pub2-BIB0037|cit37","first-page":"40","article-title":"Once-daily tiotropium improves lung function and reduces risk of asthma exacerbation\/worsening in patients with symptomatic asthma, regardless of allergic status","volume":"68","author":"Dahl","year":"2013","journal-title":"Allergy"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0038|cit38","unstructured":"Doherty DE Castro M Moroni-Zentgraf P Engel M Luehmann R Buhl R Tiotropium respimat add-on therapy improves lung function, as measured by peak expiratory flow, in adult patients across severities of symptomatic asthma American Thoracic Society International Conference; 2015 May 15-20; Denver 2015 A4258"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"88A","DOI":"10.1378\/chest.1702143","article-title":"Improvements in lung function with tiotropium as add-on controller therapy to ICS+LABA for patients with symptomatic severe asthma","volume":"144","author":"Doherty","year":"2013","journal-title":"Chest"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0040|cit40","unstructured":"FitzGerald JM Engel M Moroni-Zentgraf P Luehmann R Bleecker ER Once-daily tiotropium respimat add-on therapy improves symptom control across severities of symptomatic asthma, independent of allergic status American Thoracic Society Internation Conference; 2015 May 15-20; Denver 2015 A4263"},{"issue":"Suppl S2","key":"10.1002\/14651858.CD011721.pub2-BIB0041|cit41","first-page":"137","article-title":"Efficacy of once-daily tiotropium Respimat 5 \u03bcg from five phase III trials in adults with symptomatic asthma","volume":"20","author":"Frith","year":"2015","journal-title":"Respirology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011721.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"A152","DOI":"10.1136\/thoraxjnl-2013-204457.320","article-title":"Tiotropium is effective in patients with severe asthma without evidence of chronic obstructive pulmonary disease","volume":"68","author":"Halpin","year":"2013","journal-title":"Thorax"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011721.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"A149","DOI":"10.1136\/thoraxjnl-2013-204457.314","article-title":"Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics including markers of allergic status","volume":"68","author":"Halpin","year":"2013","journal-title":"Thorax"},{"issue":"S2","key":"10.1002\/14651858.CD011721.pub2-BIB0044|cit44","first-page":"88","article-title":"Once-daily tiotropium as add-on to ICS + LABA for patients with severe symptomatic asthma: Baseline characteristics in Japanese patients","volume":"18","author":"Hashimoto","year":"2013","journal-title":"Respirology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011721.pub2-BIB0045|cit45","first-page":"175","article-title":"Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics","volume":"18","author":"Hozawa","year":"2013","journal-title":"Respirology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0046|cit46","first-page":"16","article-title":"Tiotropium reduces asthma exacerbations in patients with uncontrolled asthma and persistent airflow obstruction despite treatment in accordance with guidelines","volume":"17","author":"Kerstjens","year":"2012","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0047|cit47","first-page":"A1312","article-title":"Tiotropium Respimat\u00ae add-on therapy to inhaled corticosteroids (ICS) + long-acting \u03922-agonists (LABAS) in patients with symptomatic severe asthma: efficacy by level of airway obstruction [Abstract]","volume":"189","author":"Kerstjens","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"13","key":"10.1002\/14651858.CD011721.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0049|cit49","unstructured":"Kerstjens HAM Engel M Dahl R Paggiaro P Beck E Vandewalker M Tiotropium respimat add-on therapy to inhaled corticosteroids (ICS) + long-acting beta 2 -agonists (LABAS) in patients with symptomatic severe asthma: Efficacy by level of airway obstruction American Thoracic Society International Conference; 2014 May 16-21; San Diego 2014 A1312"},{"issue":"s98","key":"10.1002\/14651858.CD011721.pub2-BIB0050|cit50","first-page":"41","article-title":"Tiotropium added to inhaled corticosteroids and long-acting beta(2)-agonists reduces episodes of asthma worsening, irrespective of selected patient baseline characteristics","volume":"68","author":"Kerstjens","year":"2013","journal-title":"Allergy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0051|cit51","first-page":"6 [221]","article-title":"Tiotropium provides sustained bronchodilation in patients with uncontrolled asthma and persistent airflow obstruction despite treatment in accordance with guidelines [Abstract]","volume":"17","author":"Kerstjens","year":"2012","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0052|cit52","unstructured":"NCT00776984 Evaluation of tiotropium 5 \u00b5g\/day delivered via the Respimat\u00ae inhaler over 48 weeks in patients with severe persistent asthma on top of usual care (study II) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00776984"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"A49","DOI":"10.1136\/thoraxjnl-2014-206260.97","article-title":"Once-daily tiotropium Respimat add-on to ICS + LABA improves symptom control and reduces exacerbations in patients with symptomatic asthma","volume":"69","author":"Price","year":"2014","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1378\/chest.1994283","article-title":"Once-daily tiotropium Respimat add-on to ICS+LABA reduces risk of severe exacerbation and asthma worsening in patients with asthma, independent of degree of airflow obstruction","volume":"146","author":"Tashkin","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"90A","DOI":"10.1378\/chest.1701739","article-title":"Once-daily tiotropium reduces risk of exacerbations and asthma worsening in patients with symptomatic asthma despite treatment with inhaled corticosteroids and long-acting beta2-agonists","volume":"144","author":"Tashkin","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"AB1","DOI":"10.1016\/j.jaci.2012.12.680","article-title":"Efficacy of tiotropium in patients with asthma in relation to allergic status [Abstract]","volume":"131","author":"Vandewalker","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0057|cit57","first-page":"A105","article-title":"Once-daily tiotropium Respimat add-on to maintenance therapy improves lung function in patients with moderate or severe symptomatic asthma, independent of T helper 2 inflammatory status","volume":"113","author":"Vandewalker","year":"2014","journal-title":"Annals of Allergy, Asthma and Immunology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0058|cit58","unstructured":"NCT02127697 Study of efficacy and safety of NVA237 in patients with poorly controlled asthma https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02127697"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD011721.pub2-BIB0059|cit59","first-page":"65","article-title":"Once-daily tiotropium respimat is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS) + long-acting B2-agonist (LABA): A randomized, double-blind, placebo-controlled study","volume":"19","author":"Ichinose","year":"2014","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0060|cit60","unstructured":"NCT01340209 Evaluation of tiotropium 2.5 and 5 \u00b5g once daily delivered via the Respimat inhaler compared to placebo in patients with moderate to severe persistent asthma https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01340209"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"e0124109","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium Respimat is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: A randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0062|cit62","first-page":"A1311","article-title":"Once-daily tiotropium respimat\u00ae is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS \u00b1 long-acting \u03922-agonist (LABA): a randomized, double-blind, placebo-controlled study [Abstract]","volume":"189","author":"Ohta","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0063|cit63","unstructured":"2009-018006-21 A phase II, randomised, double- blind, placebo controlled, cross-over efficacy and safety comparison of tiotropium 5 \u03bcg administered once daily (in the evening) and tiotropium 2.5 \u03bcg administered twice daily delivered by the Respimat\u00ae inhaler for four weeks versus placebo in patients with moderate persistent asthma https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2009-018006-21\/results"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0064|cit64","unstructured":"2010-018471-26 A phase II randomised, double-blind, placebo controlled, cross-over efficacy and safety comparison of three doses of tiotropium inhalation solution delivered via Respimat\u00ae inhaler (1.25, 2.5 and 5.0 \u03bcg once daily) versus placebo in patients with moderate persistent asthma https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2010-018471-26\/results"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"s97","key":"10.1002\/14651858.CD011721.pub2-BIB0066|cit66","first-page":"376","article-title":"Once-daily add-on tiotropium: a dose-finding trial in adult patients with moderate persistent asthma","volume":"68","author":"Beeh","year":"2013","journal-title":"Allergy"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-15-61","article-title":"Tiotropium Respimat in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma","volume":"15","author":"Beeh","year":"2014","journal-title":"Respiratory Research"},{"issue":"Suppl 58","key":"10.1002\/14651858.CD011721.pub2-BIB0068|cit68","first-page":"P905","article-title":"Once-daily tiotropium respimat add-on to at least ICS in adult patients with symptomatic asthma: Pooled safety analysis","volume":"44","author":"Dusser","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD011721.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.rmed.2006.11.001","article-title":"A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma","volume":"101","author":"Fardon","year":"2007","journal-title":"Respiratory Medicine"},{"issue":"Suppl 58","key":"10.1002\/14651858.CD011721.pub2-BIB0070|cit70","first-page":"1894","article-title":"Once-daily tiotropium respimat add-on to ICS+\/-LABA improves control across asthma severities","volume":"44","author":"FitzGerald","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0071|cit71","unstructured":"Haggart K Fardon TC Lee DKC Lipworth BJ Stepping down inhaled steroids in severe asthma with long acting bronchodilators: utilising effort dependent and independent measures of pulmonary function [Abstract] British Thoracic Society Winter Meeting; 2004 Dec 1-3; London, United Kingdom 2004 ii72"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"A178","DOI":"10.1136\/thoraxjnl-2014-206260.359","article-title":"Once-daily tiotropium Respimat: safety and tolerability results from five phase iii trials in adults with symptomatic asthma","volume":"69","author":"Haughney","year":"2014","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0073|cit73","first-page":"17","article-title":"Clinical observation for triple therapy in the treatment of 30 patients with bronchial asthma","volume":"22","author":"Jiang","year":"2006","journal-title":"Hunan Zhongyi Zazhi [Hunan Journal of Traditional Chinese Medicine]"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"s97","key":"10.1002\/14651858.CD011721.pub2-BIB0075|cit75","first-page":"377","article-title":"Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Trial design and planned statistical analyses","volume":"68","author":"Casale","year":"2013","journal-title":"Allergy"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0076|cit76","first-page":"A108","article-title":"24-hour lung function response to tiotropium Respimatadd-on to maintenance therapy in symptomatic patients with moderate persistent asthma","volume":"113","author":"Casale","year":"2014","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"AB5","DOI":"10.1016\/j.jaci.2013.12.040","article-title":"Tiotropium respimat add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of Th2 inflammatory status","volume":"133","author":"Casale","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0079|cit79","unstructured":"Kerstjens HAM Bleecker E Meltzer E Casale T Pizzichini E Schmidt O Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate European Respiratory Society Annual Congress; 2013 7-11 Sept; Barcelona 2013"},{"issue":"1","key":"10.1002\/14651858.CD011721.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rmed.2014.09.012","article-title":"The effect of fluticasone furoate\/umeclidinium in adult patients with asthma: a randomized, dose-ranging study","volume":"109","author":"Lee","year":"2015","journal-title":"Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011721.pub2-BIB0081|cit81","first-page":"57","article-title":"Tiotropium Respimat in asthma: evaluation of dosing regimens","volume":"23","author":"Lommatzsch","year":"2014","journal-title":"Allergo Journal"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0082|cit82","first-page":"A107","article-title":"Once-daily tiotropium Respimat add-on to inhaled corticosteroids + long-acting beta2-agonists improves lung function and asthma control and reduces risk of asthma worsening in patients with moderate or severe asthma","volume":"113","author":"Murphy","year":"2014","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0083|cit83","unstructured":"NCT01573624 A multi-center, randomized, double-blind, dose-ranging study to evaluate GSK573719 in combination with fluticasone furoate, fluticasone furoate alone, and an active control of fluticasone furoate\/vilanterol combination in subjects with asthma http:\/\/clinicaltrials.gov\/show\/NCT01573624"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0084|cit84","unstructured":"NCT02039011 Proof of concept study to evaluate single and chronic dosing effects of ultra-long acting bronchodilator therapy on mannitol challenge in asthmatic patients taking inhaled corticosteroids - MAN02 Ultra-long Acting Bronchodilator Therapy in Asthmatics http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2013-001953-28-GB"},{"issue":"Suppl 57","key":"10.1002\/14651858.CD011721.pub2-BIB0085|cit85","first-page":"877s [P4133]","article-title":"Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: design and planned analyses [Abstract]","volume":"42","author":"Paggiaro","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4997\/JRCPE.2010.425","article-title":"Tiotropium bromide in asthma patients: an alternative to inhaled long-acting beta-agonists?","volume":"40","author":"Lane","year":"2010","journal-title":"Journal of the Royal College of Physicians of Edinburgh"},{"issue":"18","key":"10.1002\/14651858.CD011721.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2013.08.003","article-title":"Predictors of response to tiotropium versus salmeterol in asthmatic adults","volume":"132","author":"Peters","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011721.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"A50","DOI":"10.1136\/thoraxjnl-2014-206260.98","article-title":"Efficacy of once-daily tiotropium Respimat 5 mug from five phase III trials in adults with symptomatic asthma","volume":"69","author":"Price","year":"2014","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clinthera.2014.02.006","article-title":"Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study","volume":"36","author":"Rajanandh","year":"2014","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clinthera.2014.12.008","article-title":"Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trial","volume":"37","author":"Rajanandh","year":"2015","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011721.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/1440-1681.12239","article-title":"Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial","volume":"41","author":"Rajanandh","year":"2014","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1378\/chest.14-1698","article-title":"What is the role of tiotropium in asthma?: a systematic review with meta-analysis [Review]","volume":"147","author":"Rodrigo","year":"2015","journal-title":"Chest"},{"issue":"Suppl 53","key":"10.1002\/14651858.CD011721.pub2-BIB0094|cit94","first-page":"E276","article-title":"Eight weeks of treatment with tiotropium plus fluticasone (t + f ) produces an equally effective therapeutic response as salmeterol plus fluticasone (s + f) in subjects with moderate-to-severe asthma [Abstract]","volume":"34","author":"Salvi","year":"2009","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD011721.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rmed.2014.12.005","article-title":"Once-daily tiotropium Respimat 5 mug is an efficacious 24-h bronchodilator in adults with symptomatic asthma","volume":"109","author":"Timmer","year":"2015","journal-title":"Respiratory Medicine"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD011721.pub2-BIB0096|cit96","first-page":"A54","article-title":"Once-daily tiotropium Respimat add-on therapy improves lung function in adolescent patients with moderate symptomatic asthma, independent of t helper 2 inflammatory status","volume":"115","author":"Vandewalker","year":"2015","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"698A","DOI":"10.1378\/chest.1994562","article-title":"Once-daily tiotropium Respimat add-on to medium-dose ics is an efficacious 24-hour bronchodilator in adolescent patients with symptomatic asthma","volume":"146","author":"Vogelberg","year":"2014","journal-title":"Chest"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0098|cit98","first-page":"389","article-title":"Dose-ranging study of tiotropium as treatment for moderate persistent asthma in adolescents","volume":"22","author":"Vogelberg","year":"2013","journal-title":"Allergo Journal"},{"issue":"2","key":"10.1002\/14651858.CD011721.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pupt.2012.09.007","article-title":"Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes","volume":"26","author":"Yoshida","year":"2013","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0100|cit100","unstructured":"NCT01696214 A pilot study to determine the feasibility and utility of implementing of the full scale TOM trial (SAPS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01696214"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002738.pub2","article-title":"Beclomethasone versus placebo for chronic asthma","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003135.pub4","article-title":"Fluticasone versus placebo for chronic asthma in adults and children","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD011721.pub2-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011397.pub2","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma","author":"Anderson","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0104|cit104","unstructured":"British Thoracic Society\/Scottish Intercollegiate Guidelines Network British guideline on the management of asthma, October 2014 https:\/\/www.brit-thoracic.org.uk\/guidelines-and-quality-standards\/asthma-guideline\/"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005535.pub2","article-title":"Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children","author":"Ducharme","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011721.pub2-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005533.pub2","article-title":"Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma","author":"Ducharme","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0107|cit107","unstructured":"Electronic Medicines Compendium License extension 19th September 2014: Spiriva Respimat 2.5 micrograms solution for inhalation https:\/\/www.medicines.org.uk\/emc\/history\/20134"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0108|cit108","unstructured":"Global Initiative for Asthma Global strategy for asthma management and prevention http:\/\/www.ginasthma.org\/"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0109|cit109","unstructured":"International Union Against Tuberculosis and Lung Disease The Global Asthma Report 2011 http:\/\/theunion.org\/what-we-do\/publications\/technical\/global-asthma-report"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0110|cit110","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro 2008"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0111|cit111","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMc1213076","article-title":"Tiotropium in asthma [correspondence]","volume":"367","author":"Kerstjens","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011721.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy","volume":"159","author":"Lipworth","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011721.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bcp.12123","article-title":"Emerging role of long acting muscarinic antagonists for asthma","volume":"77","author":"Lipworth","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD011721.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011721.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1476-5381.2010.01190.x","article-title":"Muscarinic receptor antagonists, from folklore to pharmacology: finding drugs that actually work in asthma and COPD","volume":"163","author":"Moulton","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0117|cit117","unstructured":"Royal College of Physicians Why asthma still kills: the national review of asthma deaths www.rcplondon.ac.uk\/sites\/default\/files\/why-asthma-still-kills-full-report.pdf"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011721.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874306401408010059","article-title":"Systemic effects of inhaled corticosteroids: an overview","volume":"8","author":"Pandya","year":"2014","journal-title":"The Open Respiratory Medicine Journal"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0119|cit119","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011721.pub2-BIB0120|cit120","article-title":"Respiratory disorders: chronic obstructive pulmonary disease","volume-title":"Therapeutic Choices","author":"McIvor","year":"2014"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4187\/respcare.02703","article-title":"Tiotropium versus placebo for inadequately controlled asthma: a meta-analysis","volume":"59","author":"Tian","year":"2014","journal-title":"Respiratory Care"},{"issue":"5","key":"10.1002\/14651858.CD011721.pub2-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011721","article-title":"Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA\/ICS) versus LABA\/ICS for adults with asthma","author":"Kew","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011721.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T04:17:28Z","timestamp":1713068248000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011721.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011721.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}